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ABSTRACT
Phosphorothioate-modified antisense oligodeoxy-
nucleotides (ASOs) are used to suppress gene
expression by inducing RNase H-mediated cleavage
with subsequent degradation of the target mRNA.
However, previous observations suggest that ASO/
RNase H can also result in the generation of stable
mRNA cleavage fragments and expression of trun-
cated proteins. Here, we addressed the underlying
translational mechanisms in more detail using
hepadnavirus-transfected hepatoma cells as a model
system of antisense therapy. Generation of stable
mRNA cleavage fragments was restricted to the ASO/
RNase H pathway and not observed upon cotransfec-
tion of isosequential small interfering RNA or RNase
H-incompetent oligonucleotides. Furthermore, direct
evidence for translation of mRNA fragments was
established by polysome analysis. Polysome-
associated RNA contained cleavage fragments
devoidof a 50 capstructure indicating that translation
was, at least in part, cap-independent. Further ana-
lysis of the uncapped cleavage fragments revealed
that their 50 terminus and initiation codon were only
separated by a few nucleotides suggesting a 50 end-
dependent mode of translation, whereas internal ini-
tiation could be ruled out. However, the efficiency of
translation was moderate compared to uncleaved
mRNA and amounted to 13–24% depending on the
ASO used. These findings provide a rationale for
understanding the translation of mRNA fragments
generated by ASO/RNase H mechanistically.
INTRODUCTION
Antisense technologies are widely used to suppress gene
expression in the laboratory and in the clinic as a promising
therapy of viral and malignant diseases (1–3). Most studies
to date have focused on phosphorothioate-modiﬁed antisense
oligodeoxynucleotides (ASOs) that hybridize to complement-
ary mRNA. The mRNA portion of the resulting heteroduplex
is subsequently targeted for endonucleolytic cleavage by the
ubiquitously expressed RNase H (4,5). The resulting mRNA
cleavage fragments are supposed to be rapidly degraded
by cellular exonucleases thereby rendering the message
permanently untranslatable.
However, we have reported previously that ASO-induced
cleavage of the target mRNA is not always followed by rapid
degradation of the cleavage fragments. ASO directed against
hepadnaviral mRNA resulted in the generation of stable
30 mRNA cleavage fragments in human and avian cells (6).
The expression of N-terminally truncated proteins matching
the primary sequence of the 30 mRNA cleavage fragments
suggested that these mRNA intermediates may serve as a
template for translation. Stable mRNA intermediates and
translation of truncated protein were not a peculiarity of viral
RNA and also observed using ASO directed against mRNA
encoding ﬂuorescent proteins and a cellular transcription
factor. These ﬁndings implicate that the expression of
novel polypeptides with unknown biological properties after
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doi:10.1093/nar/gki155ASO/RNase H-mediated cleavage of the target mRNA may
cause serious side effects of antisense therapy.
BesidesASO/RNase H, RNA interference (RNAi)mediated
by small interfering RNA (siRNA) is commonly used to
inhibit gene expression by inducing endonucleolytic cleavage
of the target mRNA (7). The antisense strand of siRNA guides
a nuclease complex RISC (RNA-induced silencing complex)
to the complementary target mRNA and induces its cleavage
in the center of the 21 nt siRNA/mRNA duplex, similar to
RNase Hthat cleaves 8–12 nt downstream the 50 mRNAend of
the mRNA/ASO heteroduplex (8,9). In addition, RNase H and
RISC both produce 30-hydroxy and 50-phosphate termini, and
recent analysis even revealed a similar crystal structure of the
endonucleolytic domains within RISC and RNase H (9–11).
These ﬁndings raise the question whether stable 30 mRNA
cleavage fragments and the expression of truncated proteins
also occur within the RNAi pathway.
The biological relevance of such stable cleavage fragments
will be primarily determined by their translational efﬁciency.
Translation of eukaryotic mRNA is a tightly regulated process
with initiation being the rate-limiting step. mRNA struc-
tures such as the 50 cap structure (m7GpppN) and 30 poly(A)
tail act synergistically with several eukaryotic initiation
factors (eIF) to recruit the small ribosomal subunit to the
mRNA 50 terminus (12,13). The 50 cap structure is considered
to play an essential role in this process by binding of the
heteromultimeric initiation complex eIF4F via its cap binding
subunit eIF4E. This preinitiation complex scans along the
mRNA until a favorable initiation codon is encountered
(14). As RNase H-mediated cleavage produces 50 phosphate
termini, stable 30 mRNA cleavage fragments are predicted to
lack a cap structure as conﬁrmed previously by RNA ligation
and RT–PCR (6). Several mechanisms may thus account
for the translation of the stable 30 mRNA cleavage fragments.
Initiation of translation may be cap-independent but 50
end-dependent as observed in vitro and, albeit with severely
reduced efﬁciency, in vivo (15–17). A fraction of the mRNA 30
cleavage fragments may also be recapped by an unknown
mechanism, thus enabling cap-dependent translation. The
lack of a 50 cap structure could further be bypassed by direct
binding of ribosomes to internal RNA secondary structures
called internal ribosome entry sites (IRESs) present on various
viral and cellular RNAs (18).
Here,wefurtherexaminedthetranslationofstable30 mRNA
cleavage fragments using ASO directed against duck hepatitis
B virus (DHBV) in hepatoma cells as a model system of
antisense therapy for hepadnaviral infection. Hepatitis B
virus (HBV) infection is a major cause of chronic liver disease
including liver cirrhosis and hepatocellular carcinoma (19).
DHBV and HBV share basic characteristics in viral replication
and DHBV infection is therefore a relevant experimental
model for the evaluation of new antiviral strategies (20).
The DHBV genome consists of a partially double-stranded
circular DNA of 3021 bp length. Two major viral transcripts
generated by the host cellular polymerase II include the over-
lapping pregenomic RNA (pgRNA, 2530–3021/1–2796) and
long subgenomic RNA (sgRNA 740–2796). pgRNA codes for
viral core proteins, the reverse transcriptase/DNA polymerase
and serves as a template for reverse transcription during viral
replication. The sgRNA encodes the viral surface proteins
(preS/S and S). PreS/S proteins are translated by a leaky
scanning mechanism using four distinct start codons yielding
the preS/S isoforms p36, p35, p33 and p30, respectively (21).
Thus, DHBV mRNAs are particularly suitable to study the
translation ofmRNAcleavage fragments into truncated preS/S
protein because several initiation codons yielding distinct pro-
tein isoforms are present.
Here, we provide evidence that the generation of stable 30
mRNA cleavage fragments and expression of truncated pro-
teins is restricted to the ASO/RNase H pathway. We further
demonstrate that these mRNA fragments are translated
with moderate efﬁciency and our data suggest that a 50 end-
dependent and, at least in part, cap-independent mechanism is
involved.
MATERIALS AND METHODS
Plasmids
DHBV RNAs were expressed from different plasmids:
pGemDHBV is a replication-competent head-to-tail dimer
construct coding for DHBV F16 (22), pDHBVsg codes only
for sgRNA under control of a CMV promoter (6) and HTD-
Dcore
  encodes a DHBV mutant deﬁcient of the viral core
protein(23). Renilla and ﬁreﬂy luciferase were expressed from
vectors pRL-TK and pGl2-control (Promega, Mannheim,
Germany) and a CMV promoter was inserted into pGl2 to
improve the expression in LMH cells. A preS luciferase fusion
construct (preS-Luc) was obtained by cloning a DHBV frag-
ment comprising the 50-untranslated region (50–UTR) of the
subgenomic RNA and preS region (nucleotides 740–1094) in
frame into the HindIII site of pGL2 control. The pEGFP
encodes enhanced green ﬂuorescent protein (EGFP). A dicis-
tronic vector with EGFP as the ﬁrst cistron and preS-Luc as the
second cistron was constructed by the insertion of a NheI/NotI
fragment of pEGFP comprising the open reading frame into
the 50 multiple cloning site of preS-Luc. For in vitro transcrip-
tion, the preS portion of preS-Luc including the T7 promoter
wasclonedintopT3Luc(pA)encodingapolyadenylatedﬁreﬂy
luciferase mRNA (A98) (24).
Antisense oligonucleotides
Phosphorothioate-modiﬁed high-performance liquid chro-
matography (HPLC)-puriﬁed 18mer ASO and isosequential
20-O-methyl-modiﬁed RNA oligonucleotides were obtained
from Microsynth (Balgach, Switzerland): ASO DHBV795,
50-ATGTTGCCCCATCATAAA-30; ASO DHBV874, 50-TT-
GGGATCATTCTTCCGG-30; and ASO Luc, 50-TCGAA-
GTATTCCGCGTACG-30. As controls, ASO with unrelated
sequences (ASO 54, 50-CAGTCACTAAGTCACTGG-30 or
ASO 507, 50-GGAGTCGGCCGACTCCAT-30) or a mismatch
control(ASODHBV795miss,50-ATGTTGTTTAAACATAAA-
30) were used. As no effect on the target mRNA or protein was
observed with either control ASO, only one control was in-
cludedineachexperiment.HPLC-puriﬁedsiRNAconsistingof
19mer double-stranded RNA with two 30 overhanging thymi-
dines were obtained from Xeragon (Z€ u urich, Switzerland). The
siRNA DHBV794 was directed againstDHBV794-812(50-AT-
TTATGATGGGGCAACAT-30) corresponding to the target
sequence of ASO DHBV794. Single-stranded siRNA
(ssRNA794 and asRNA794) and double-stranded siRNA with
inverse sequence were used as controls.
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The avian hepatoma cell line LMH supports replication of
DHBV (25). Cells were cultured in Isocove’s modiﬁed
Dulbecco’s medium (GIBCO-BRL, Karlsruhe, Germany).
The medium contained 7% fetal bovine serum (Biochrom,
Berlin, Germany), penicillin (100 U/ml), streptomycin
(100 mg/ml; both GIBCO-BRL) and 1% of a non-essential
amino acid stock solution (GIBCO-BRL). Cells were trans-
fected with DNA using the calcium phosphate method. In
a typical cotransfection experiment, 5 mg of plasmid DNA
and 5 mg of ASO were used per 10 cm dish. To examine
whether the effects of the different antisense compounds were
concentration-dependent, cells were seeded in 6-well plates
and cotransfected with 1 mg of plasmid DNA and different
amounts of antisense compounds (0, 0.1, 0.5, 1 and 2 mg,
respectively, corresponding to 0, 7, 33, 67 and 133 pmol of
siRNA or 0, 18, 91, 184 and 367 pmol of ASO, respectively).
Cells were harvested after 2 days for further analysis.
The Transmessenger kit (Qiagen, Hilden, Germany) was
used for RNA transfections according to the manufacturer’s
instructions. An aliquot of 1 mg of mRNA and 1 mg of ASO
were cotransfected per 6-well plate in a typical cotransfection
experiment.
RNA analysis
Total cellular RNA was isolated using the Trizol reagent
(Invitrogen, Karlsruhe, Germany) or the RNeasy kit (Qiagen).
RNA was separated on formaldehyde containing 1.2% agarose
gels, blotted onto Nylon membranes (Hybond N; Amersham
Pharmacia, Freiburg, Germany) by capillary transfer and
visualized using
32P-labeled oligo probes or DNA fragments
as indicated.
Total cellular RNA and cytoplasmic RNA were prepared
from the same sample to determine the percentage of cyto-
plasmic RNA. Cells were washed twice with phosphate-
buffered saline (PBS) and lyzed (lysis buffer 10 mM Tris,
pH 7.5, 10 mM NaCl, 8 mM MgCl2, 1 mM DTT, 1.5 mM
PMSF, 1% Triton X-100 and 0.5% sodium desoxycholate).
Nuclei and debris were removed by centrifugation at 10000
r.p.m. for 10 min in a microcentrifuge and cytoplasmic RNA
from the supernatant was isolated with Trizol. Total cellular
and cytoplasmic RNA were compared by northern-blot
analysis using probes that bind to a region 30 of the putative
cleavage site on sgRNA or to EGFP and subsequently quan-
tiﬁed using phosphorimaging.
For run-off in vitro transcription of capped mRNA, 4 mgo f
linearized DNA template was incubated with T7 transcription
buffer (Promega) containing 8 mM cap analog (m
7GpppG;
NEB, Frankfurt, Germany), nucleotide mixture (1 mM of
each CTP, ATP and UTP; Promega), RNasin (NEB) and
60 U of T7 RNA polymerase (Promega). After incubation
at 37 C for 5 min, 1 mM GTP was added and incubated
for 2 h with subsequent DNase I digestion (GIBCO-BRL).
RNA was recovered using the RNeasy kit and analyzed by
gel electrophoresis.
Polysome analysis
Polysome analysis was performed as described with minor
modiﬁcations (26). All steps were performed on ice and
cells from 2 to 5 10-cm dishes were used per gradient.
Cells were washed with ice-cold PBS containing 0.1 mg/ml
of cycloheximide and lyzed on the plate with polysome
extraction buffer (15 mM Tris–HCl, pH 7.4, 15 mM MgCl2,
0.3 M NaCl, 1% Triton X-100, 0.1 mg/ml of cycloheximide
and 1 mg/ml of heparin). Extracts were transferred to
Eppendorf tubes and incubated on ice. Nuclei and debris
were removed by centrifugation at 10000 r.p.m. for 10 min
in a microcentrifuge. Supernatants were layered onto 10 ml of
10–50% sucrose gradients composed of extraction buffer
lacking Triton X-100. The gradients were centrifuged at
35 000 r.p.m. at 4 C using a Kontron TST41.14 rotor for
190 min. After centrifugation, 30 fractions were collected
and theabsorbance at254 nmwasdeterminedforeach fraction
using a photometer. Three fractions each were pooled before
RNA isolation. MgCl2 was replaced by EDTA in the EDTA
release experiment.
RNA ligation and RT–PCR
To analyze the capping status of polysome-associated
RNA, cells were cotransfected and cytoplasmic extracts were
analyzed by sucrose gradient centrifugation. The gradient was
directly fractionated omitting the determination of the absorb-
ance proﬁle in order to minimize mRNA degradation before
RNA ligation and RT–PCR. Half of each fraction was further
analyzed by northern blotting, and the integrity of the gradient
was veriﬁed by monitoring the sedimentation pattern of con-
trol EGFP mRNA, whereas the distribution of ribosomal RNA
on the gel was used as an indirect marker for the polysome
distribution as described previously (27,28). Non-polysomal
and polysomal fractions were pooled and subsequently exam-
ined by mRNA ligation, reverse transcription, PCR, cloning
and sequencing as described previously (6).
Protein analysis
For immunoblot analysis, polyclonal antibodies against
DHBV surface antigen (6), GFP (Clontech, Heidelberg,
Germany) and ﬁreﬂy luciferase (Promega) were used.
Immunoblotting was performed using 10–12% SDS–PAGE
as described previously (6). Equal amounts of protein were
loaded.
Luciferase assays were performed using the Dual luciferase
kit according to the manufacturer’s instructions (Promega).
The ﬁreﬂy/Renilla ratio was determined and values are given
in percentage of the luciferase ratio obtained from positive
controls within the same experiment as mean values – SEM
from n observations. For statistical analyses, the independent
Student’s t-test was used and P < 0.05 was accepted to
indicate statistical signiﬁcance. The cleavage of mRNA and
expression of truncated proteins was monitored by simul-
taneous RNA analysis and immunoblotting.
RESULTS
Stable mRNA cleavage fragments are not observed
upon cotransfection of siRNA
We wondered whether the generation of stable RNA cleavage
fragments also occurs in the RNAi pathway given the similar
cleavage patterns of siRNA/RISC and ASO/RNase H. Pilot
experiments revealed that pgRNA and sgRNA expressed from
116 Nucleic Acids Research, 2005, Vol. 33, No. 1pGemDHBV were only incompletely cleaved upon cotrans-
fection with siRNAs in LMH cells. This may be explained
by stoichiometric reasons or the fact that viral RNA may be
partially protected against RISC attack by viral proteins such
as the reverse transcriptase and core, both encoded by pgRNA.
LMH cells were therefore cotransfected with a construct
yielding only sgRNA (pDHBVsg) and ASO DHBV795 or
isosequential siRNA794, each directed against a sequence
ﬂanking the ﬁrst start codon (Figure 1A). Viral mRNA was
analyzed by northern blots with probes complementary to
regions 50 and 30 from the cleavage site, respectively, so
that the resulting cleavage fragments could be distinguished.
Northern-blot analysis revealed that sgRNA was almost abol-
ished and the expression of all preS/S isoforms was equally
reduced in the corresponding immunoblots upon cotransfec-
tion with siRNA794 (Figure 1B and C). In contrast, a band
slightly smaller than sgRNA was detected by northern-blot
analysis only with the 30 probe after cotransfection with
ASO DHBV795, whereas no RNA was detected with the
50 probe consistent with complete cleavage and the generation
of stable 30 mRNA cleavage fragments. Immunoblotting
revealed the concomitant expression of p35 and p33 initiated
from the second and third initiation codon as described
earlier for pGemDHBV [see also Figures 1 and 4 in (6)].
Cotransfection of control siRNA with inverse sequence and
single-stranded sense siRNA (ssRNA794) did not inﬂuence
viral RNA or protein expression, whereas cotransfection of
single-stranded antisense siRNA (asRNA794) also caused a
decrease in the expression of sgRNA and preS/S protein
consistentwithpreviousobservationsthat asRNA isefﬁciently
incorporated into RISC (8).
To test whether these differential effects of siRNA794 and
ASO DHBV795 on sgRNA were concentration-dependent,
LMH cells were cotransfected with various amounts of anti-
sense compounds and northern-blot analysis was performed
(Supplementary Figure S1). Small amounts of uncleaved
sgRNA were still detected by both probes with all concentra-
tions of siRNA794. In contrast, one-third of sgRNA was still
detected by the 50 probe (i.e. uncleaved) with the lowest con-
centration of ASO DHBV795 but diminished to background
levels with higher concentrations. In contrast, 30 cleavage
fragments were detected with increasing concentrations of
ASO DHBV795 in approximately the same amount as
uncleaved sgRNA. It should be noted that the transfection
efﬁciency was reduced with increasing ASO amounts as
judged from the EGFP signal.
The activity of siRNA/RISC is rather localized in the
cytoplasm and intermediate mRNA cleavage fragments
generatedbysiRNA/RISCmightthereforebereadilydegraded
by the cytoplasmic RNA decay machinery. Stable 30 mRNA
cleavage fragments generated by ASO/RNase H have been
previously shown to lack a 50 cap structure, an important
enhancer of nucleocytoplasmic transport (29). If ASO/RNase
H-mediated cleavage occurred predominantly in the nucleus,
uncapped 30 mRNA cleavage fragments might accumulate
within the protected nuclear compartment and thus escape
from the cytoplasmic mRNA decay machinery. To address
this possibility, we analyzed total cellular and cytoplasmic
RNA prepared from the same cells cotransfected with
pDHBVsg and ASO by northern blotting. The distribution
of total and cytoplasmic sgRNA was not affected by cotrans-
fection of either ASO DHBV795 or DHBV795miss (Figure 2).
The amount of each RNA was quantiﬁed and revealed that
 50% of sgRNA was cytoplasmic independent of the ASO
used. The percentage of EGFP mRNA in the cytoplasm was
higher amounting to  70%. The appearance of stable 30
mRNA fragments upon ASO/RNase H-mediated cleavage is
therefore not due to nuclear accumulation.
Oligonucleotides with a modiﬁcation in the 20 position such
as 20-O-methyl are RNase H-incompetent and can therefore
be used as a negative control to demonstrate the involvement
of RNase H in antisense experiments (4,30). In contrast to
the effects observed after cotransfection of ASO DHBV795,
the expression of viral mRNA and surface proteins was not
inﬂuenced by cotransfection of pGemDHBV and isosequential
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Figure 1. ASO and siRNA differently influence target mRNA stability and
translation. (A) Schematic diagram of DHBV sgRNA. The initiation codons,
hybridization sites for antisense oligos and labeled probes are depicted. The
drawing is not to scale. (B) Northern-blot analysis with probes discriminating
the putative mRNA cleavage fragments upon cotransfection of hepatoma cells
with a construct encoding sgRNA and different antisense compounds. Equal
amounts of RNA were loaded. (C) Immunoblotting of the concomitantly
expressed preS/S proteins, different isoforms are indicated. Equal amounts
of protein were loaded.
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indirect evidence that RNase H is involved in the generation
of stable 30 mRNA cleavage fragments (data not shown).
Association of stable 30 mRNA cleavage fragments with
polysomes
We next aimed at establishing a more direct link between
cytoplasmic mRNA cleavage fragments and the translation
apparatus by polysome analysis using sucrose gradient
centrifugation. Expression plasmids encoding both pgRNA
and sgRNA were used in these experiments (Figure 3A).
Pilot experiments revealed that the sedimentation patterns
of RNA-containing core particles and polysomes overlap
(data not shown). Hepatoma cells were therefore cotransfected
with a DHBV core deletion mutant (pHTD-Dcore
 ), dif-
ferent ASO and EGFP as internal control. However, cotrans-
fection of ASO DHBV795 with pHTD-D core
  or wild-type
pGemDHBV was shown to result in a similar distribution of
stable 30 mRNA cleavage fragments over the gradient because
the core was not expressed after endonucleolytic cleavage
of pgRNA (data not shown). Sucrose gradient centrifugation
of cytoplasmic extracts was performed and fractions were
analyzed by northern blotting. The absorbance proﬁle indi-
cated that polysomes were present throughout fractions 7–10
(Figure 3B). The proﬁle and the polysomal association of
control EGFP mRNA were not affected by the different
ASO used. Northern-blot analysis revealed two major bands
of viral RNA corresponding to pgRNA and sgRNA with
pgRNA being more abundantly expressed. Uncleaved sgRNA
was predominantly found in polysomal fractions 9 and 10,
whereas pgRNA was evenly distributed throughout the
gradient, consistent with a moderate translational efﬁciency.
This was expected for the core-deﬁcient pgRNA transcribed
from pHTD-Dcore
  because core is a major gene product
of pgRNA. pgRNA was no longer detectable after cotrans-
fection of ASO DHBV795 consistent with complete mRNA
cleavage. The signal co-migrating with 5S RNA in the super-
natant is most likely due to unspeciﬁc labeling of small
RNA and degradation products. Stable 30 mRNA cleavage
fragments predominantly co-sedimented with non-polysomal
fractions 2–5; however, a signiﬁcant amount of mRNA still
co-sedimented with polysomal fractions 7–10. These ﬁndings
indicate that the stable 30 mRNA cleavage fragments serve as
a template for translation. But the mRNA distribution was
consistent with a reduced translational efﬁciency compared
to uncleaved sgRNA or mRNA coding for EGFP. To test
whether the mRNA sedimentation properties were determined
by the binding of polysomes, the sedimentation proﬁles were
also examined by sucrose gradient centrifugation after MgCl2
was replaced by EDTA. This causes the dissociation of ribo-
somes from mRNA, whereas most non-ribosomal RNA–
protein complexes are not disrupted (26). In the presence of
EDTA, viral and EGFP mRNA co-sedimented predominantly
with fractions 2–4 indicating that the sedimentation proﬁle
was indeed due to polysomal association (Supplementary
Figure 2). Careful analysis of the gradients revealed that
non-polysomal pgRNA migrated further into the gradient
than non-polysomal sgRNA or EGFP mRNA. This difference
was still detected after the dissociation of ribosomes in the
presence of EDTA and may be determined by the size of the
respective RNAs. In conclusion, these data provide direct
evidence that cytoplasmic 30 mRNA cleavage fragments
serve as a template for translation in hepatoma cells even
if the polysomal distribution was consistent with reduced
translational efﬁciency.
Translation of stable 30 mRNA cleavage fragments is,
at least in part, cap-independent but 50 end-dependent
Stable 30 mRNA cleavage fragments isolated from total
cellular extracts were shown previously to be uncapped by
RNA ligation and subsequent RT–PCR (6). Therefore, it was
questioned whether translation of these fragments involves a
cap-independent mechanism or whether recapping occurs. If
recapping was essentially required for the translation of stable
30 mRNA cleavage fragments, no uncapped fragments should
be detected in the polysome-associated RNA. To address this
question,LMH cellswere cotransfectedwithpGemDHBVand
ASO DHBV795 followed by sucrose gradient centrifugation
of cytoplasmic extracts. After fractionation, the gradient was
directly analyzed by northern blotting without prior deter-
mination of the absorbance in order to minimize mRNA
degradation before ligation and RT–PCR. The integrity of the
gradient was instead veriﬁed by monitoring the sedimentation
pattern of EGFP mRNA as internal control and the ribosomal
RNA as described previously (27,28). Polysomal fractions
12–18 (corresponding to fractions 7–10 in Figure 3B) and
non-polysomal fractions 4–10 (corresponding to fractions
2–5 in Figure 3B) were pooled and subsequently analyzed
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In this assay, ligation and subsequent ampliﬁcation of an
 0.4 kb PCR product comprising the poly(A) tail, cleavage
site and adjacent sequences only occurs if the mRNA 50 term-
inus is phosphorylated (i.e. uncapped, Figure 4A). It should
be noted that only DHBV RNA ligated to its own 30 terminus
or to another DHBV RNA is ampliﬁed in this protocol. It is
therefore likely that only a very small subset of uncapped 30
mRNA cleavage fragments is detected with this assay given
the vast amount of unrelated mRNA 30 termini present in the
cell. However, PCR products with the predicted size could
indeed be ampliﬁed from the polysomal and non-polysomal
pools indicating that these pools include uncapped 30 mRNA
cleavage fragments (Figure 4B). It should be noted that two
further PCR products were generated by internal binding of
the primers on pgRNA and residual viral DNA. Their ampli-
ﬁcation was comparatively efﬁcient because it did not neces-
sitate ligation of the mRNA, the rate-limiting step of this
protocol (6). These ﬁndings suggest that a cap-independent
mode of translation qualitatively contributes to the generation
of truncated proteins from stable 30 mRNA cleavage frag-
ments. However, as it cannot be ruled out that the cleavage
fragments are recapped in parallel thus supporting a cap-
dependent mode of translation, the impact of cap-
independent translation cannot be assessed more quantita-
tively with this assay.
The  0.4 kb PCR fragments were analyzed further by
cloning and sequencing. The cleavage sites determined in 12
clones were located in the 30 region of the ASO/mRNA het-
eroduplex consistent with endonucleolytic cleavage by RNase
H (Figure 4C). In parallel, expression of p35 and p33 was
observed by immunoblotting of the cytoplasmic extracts
(data not shown). Sequencing of the clones obtained from
the polysomal pool revealed that the distance between the
50 terminus and the next start codon yielding p35 was very
short comprising only 7–20 nt. This short distance suggests
thatthe translationof30 mRNA cleavage fragmentsinvolves50
end-dependent binding of ribosomes.
Figure 3. Stable30 mRNAcleavagefragmentsareassociatedwithpolysomes.(A)SchematicdiagramofthemajortranscriptsofDHBV.Thedrawingisnottoscale.
(B) Polysome analysis of mRNA after cotransfection with control ASO 54 (B) or ASO DHBV795 (C) by sucrose gradient centrifugation. Cytoplasmic extracts
were separated on a 10–50% sucrose gradient and fractionated. After fractionation, the absorbance at 254 nm was determined for each of the 30 fractions and is
shownat the topofeach panel.The positionofnon-polysomalribosomal subunits(arrows)and ofpolysomesis indicated.Fractionsfrom the bottomof thegradient
are shown on the right. Three fractionseach were pooledand equal volumesof each fractionwere loaded fornorthern-blotanalysis using labeledDHBV and EGFP
DNA fragments as a probe, respectively. The positions of pgRNA, sgRNA and 30 cleavage fragments are indicated. The polysomal distribution of EGFP RNA was
used as internal control.
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with moderate efficiency
Translational efﬁciency will be critical to determine the
functional relevance of uncapped 30 mRNA cleavage
fragments. We therefore sought a more quantitative assay to
determine the translational efﬁciency using a construct con-
sisting of the sgRNA 50-UTR and preS portion fused in frame
to ﬁreﬂy luciferase (preS-Luc; Figure 5A). We anticipated that
the yield of luciferase fusion proteins shouldbe a good indirect
marker for translational efﬁciency. LMH cells were cotrans-
fected with preS-Luc, a Renilla luciferase construct as internal
control and different ASO, and subsequently analyzed by
northern-blot analysis and immunoblotting. Luciferase activ-
ity was normalized to the cotransfected Renilla control to
account for differences in transfection efﬁciency or unspeciﬁc
effects of the respective ASO on gene expression.
Cotransfection of preS-Luc with each ASO resulted in
the generation of distinct stable 30 mRNA cleavage fragments,
and faint bands consistent with 50 cleavage fragments were
detected by the 50 probe (Figure 5B). Interestingly, the amount
of 30 cleavage fragments was increased 3-fold upon cotrans-
fection with ASO DHBV795 and 2-fold after cotransfection
with ASO DHBV874, but remained unchanged upon cotrans-
fection with ASO Luc. This was paralleled by increased
expression of Renilla luciferase. We therefore hypothesize
that cotransfection of the respective ASO may inﬂuence the
transfection efﬁciency of the luciferase plasmids. However,
this effect was accounted for by the normalization of ﬁreﬂy to
Renilla luciferase activity. Truncated preS luciferase fusion
proteins were identiﬁed by immunoblotting using antibodies
against preS and luciferase (Figure 5C and data not shown).
Size analysis and comparison to the expression pattern of
preS/S proteins suggested that the synthesis of preS-Luc pro-
teinswaspredominantlyinitiatedattheﬁrststartcodonandthe
fourth start codon. After cotransfection with ASO DHBV795
directed against the ﬁrst start codon, the predominant bands
were consistent with translation from the second start codon
and from the fourth start codon. Luciferase activity was
signiﬁcantly reduced to 13.2 – 1.7% (n = 12) compared to
translation from uncleaved mRNA. A single band consistent
with a fusion protein initiated from the fourth start codon was
detected by immunoblotting after cotransfection with ASO
DHBV874 directed against the third start codon. Interestingly,
luciferase activity was reduced to a lesser extent than after
cotransfection of ASO DHBV795 (24.9 – 5.5%, n = 6). These
ﬁndings indicate that stable 30 mRNA cleavage fragments are
translated with moderate efﬁciency which is inﬂuenced by the
ASO used.
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levels after cotransfection of ASO Luc directed against the
luciferase initiation codon (0.6 – 0.1%, n = 4). Interestingly,
cotransfection of ASO Luc also resulted in the generation of
stable 30 mRNA cleavage fragments even ifnoinitiationcodon
with favorable Kozak consensus sequence was available
downstream the cleavage site. This ﬁnding indicates that
translation is unlikely to be required for the stabilization of
30 mRNA cleavage fragments. Furthermore, stable 30 mRNA
cleavage fragments generated after cotransfection of preS-Luc
and ASO DHBV795 were also efﬁciently ligated and did
therefore not differ from DHBV fragments with regard to
their capping status (data not shown).
The DHBV preS region does not exhibit IRES activity
To exclude the possibility that IRES activity within the DHBV
preS region may account for the translation of uncapped 30
mRNA cleavage fragments, a dicistronic vector with EGFP as
ﬁrst cistron and preS-Luc as second cistron was designed
(Figure 6A). Dicistronic vectors are commonly used to study
IRES activity because translation of the downstream cistron
does usually not occur in the absence of an IRES (18). The
dicistronic construct was cotransfected with control ASO or
ASO DHBV795. Monocistronic preS-Luc served as positive
control. After cotransfection of control ASO, the 50 cistron
EGFP was readily expressed, whereas no luciferase fusion
proteins could be detected indicating that no signiﬁcant
IRES activity was present within the DHBV preS region
(luciferase activity 0.8 – 0.1%, n = 3; Figure 6B). After
cotransfection of ASO DHBV795, stable 30 mRNA cleavage
fragments with the same size as the fragments obtained after
cotransfection of monocistronic preS-Luc mRNA were
observed by northern-blot analysis (data not shown). EGFP
expression decreased after ASO-mediated cleavage of the
bicistronic RNA, whereas luciferase expression was restored
to levels obtained after cleavage of monocistronic RNA
(monocistronic 13.5 – 1% versus dicistronic 13.6 – 0.3%,
n = 3 each; Figure 6B). Residual EGFP expression after
cotransfection with ASO DHBV795 is explained by a small
amount of uncleaved dicistronic mRNA. Therefore, IRES
activity was not present within the DHBV preS region and
did not contribute to the translation of uncapped 30 mRNA
cleavage fragments.
Contribution of the subcellular compartment to the
generation of stable 30 mRNA cleavage fragments
RNase H activity has been observed in the nucleus and in
the cytoplasm, respectively (5). A cytoplasmic activity of
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Nucleic Acids Research, 2005, Vol. 33, No. 1 121ASO/RNaseHmayfacilitatethetranslationofstable30 mRNA
cleavage fragments because ribosomes could then be recruited
by a cap-dependent mechanism before endonucleolytic cleav-
age.TheseribosomescouldthencycleonmRNAcleavagefrag-
ments and support their translation even if the capped 50 end
was removed by endonucleolytic cleavage. To address this
possibility, in vitro transcribed, capped and polyadenylated
preS-Luc mRNA was cotransfected with ASO DHBV795 and
Renilla mRNA as internal control. We assumed that trans-
fected in vitro transcribed mRNA should be localized within
the cytoplasm and that the effects observed after cotransfec-
tion should therefore reﬂect a cytoplasmic event. Cells were
harvested 4 h after transfection and analyzed. Surprisingly,
mRNA was quantitatively not inﬂuenced by ASO DHBV795
and no cleavage fragments were observed (Figure 7A). In
contrast, the expression of luciferase fusion proteins was sig-
niﬁcantly reduced to 5.5 – 0.3% (n = 4) after cotransfection of
ASO DHBV795 compared with the cotransfection of control
ASO (Figure 7B). These ﬁndings suggest that the decline
in luciferase activity was rather due to sterical inhibition of
translationthan tocytoplasmicactivityofRNaseH.Inkeeping
with this notion, immunoblotting revealed that expression of
all preS-Luc isoforms was equally reduced and no shift of
translation towards smaller isoforms was observed (data not
shown). The absence of cytoplasmic RNase H activity
indicates that the translation of stable 30 mRNA cleavage
fragments is unlikely to involve cap-dependent initiation of
translation prior to cytoplasmic cleavage.
DISCUSSION
Our observation of stable 30 mRNA cleavage fragments may
severely counteract ASO/RNase H-based applications by
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122 Nucleic Acids Research, 2005, Vol. 33, No. 1the expression of truncated proteins. To address the question
whether the generation of stable 30 mRNA cleavage fragments
is restricted to the ASO/RNase H pathway, we compared the
effects of isosequential ASO and siRNA directed against
hepadnaviral sequences because similar cleavage patterns
have been reported for RNase H and RISC (8,9). Furthermore,
RISC-induced cleavage fragments have been observed in
cytoplasmic extracts from human and Drosophila cells (8,31).
In contrast, we could not observe any stable mRNA fragments
and translation of truncated proteins after the cotransfection of
siRNA directed against hepadnaviral sequences in hepatoma
cells. In addition to previous studies comparing the action of
siRNA and ASO quantitatively (32,33), our results suggest
that siRNA may be safer than ASO with respect to potential
side effects resulting from the generation of stable mRNA
cleavage fragments and their translation. It is not known how
the mRNA fragments resulting from siRNA/RISC-mediated
cleavage are further degraded, but an additional RISC-
associated exonucleolytic activity may be involved in this
process (34).
Size analysis of the cleavage fragments, determination of
the cleavage sites by RNA ligation and the observation that
cleavage could not be induced by RNase H-incompetent
oligonucleotides all suggest that RNase H is involved in the
generation of stable 30 mRNA cleavage fragments. At least
two different isoforms of cellular RNase H have been char-
acterized, but direct evidence for their involvement in the ASO
pathway is still limited (5,9,35). RNase H activity has also
been isolated from various viruses including DHBV (36).
However, hepadnaviral RNase H was unlikely to contribute
to our ﬁndings because stable 30 mRNA cleavage fragments
were also observed after cotransfection of constructs without
viral RNase H activity, such as pDHBVsg or preS-Luc. We
therefore conclude that the generation of stable 30 mRNA
cleavage fragments is restricted to endonucleolytic cleavage
induced by ASO and cellular RNase H.
We furthermore provide direct evidence that mRNA
cleavage fragments assemble with polysomes and serve as a
template for translation. Analysis of polysome-associated
cleavage fragments also revealed insights into the mechanisms
contributing to their translation. The 50 cap structure is con-
sidered to play an essential role in promoting initiation of
translation in vitro and in vivo (16,17,37). RNA ligation
and subsequent RT–PCR was used here to conﬁrm that
uncapped mRNA cleavage fragments are associated with
polysomes, suggesting that a cap-independent mechanism
qualitatively contributes to the translation of stable 30
mRNA cleavage fragments. However, it cannot be ruled out
that the cleavage fragments are recapped in parallel thus
supportingacap-dependent modeoftranslationandtheimpact
of cap-independent translation cannot be assessed more quan-
titatively with this assay. Capping is a very early event of
mRNA transcription occurring after  20–30 nt have been
synthesized and necessitates close interactions between the
capping enzymes and RNA polymerase II (29,38). To our
knowledge, a reaction that adds a 50 cap structure to an other-
wise mature mRNA has not been described so far, raising
the question whether recapping of stable 30 mRNA cleavage
fragments occurs in the cell.
Several mechanisms may account for the translation of
uncapped mRNA including 50 end-dependent or internal
binding of ribosomes (39). Only few studies have examined
cap-independent translation in the absence of an IRES struc-
ture in vivo. It was shown that 50 end-dependent binding of
ribosomes with subsequent ribosomal scanning was involved
in the translation of uncapped RNA generated by polymerase
III (40,41). More insights regarding the initiation factors that
mediate ribosomal binding to the 50 terminus stem from
experiments with translation extracts, where it has been shown
in vitro that the central domain of eIF4G may be involved, and
that translation of uncapped mRNA was even enhanced upon
proteolytic cleavage of eIF4G (15,42). In addition, structures
within the 30-UTR such as the poly(A) tail or viral seq-
uences have also been shown to mediate the recruitment of
ribosomes to the mRNA (16,43). However, most examples of
cap-independent translation in viral and cellular mRNAs have
been reported to involve IRES-mediated initiation.
Our data suggest that stable 30 mRNA cleavage fragments
are translated by a 50 end-dependent mechanism and sub-
sequentribosomal scanning forthe following reasons. Sequen-
cing of polysome-associated and uncapped stable 30 mRNA
cleavage fragments revealed that the initiation codon giving
rise tothe preS/S p35 isoform andthe 50 terminusare separated
by only 7–20 nt. This short distance shouldbe sufﬁcient for the
attachment of ribosomes to the 50 end because translation of an
uncapped mRNA with a distance of only 8 nt between the 50
terminus and initiation codon has earlier been reported (44).
However, the ﬁrst start codon available on stable 30 mRNA
cleavage fragments yielding p35 has a suboptimal consensus
sequenceandapositionveryclosetothe50 terminus.Thewell-
established scanning mechanism predicts that this initiation
codon will be bypassed by some of the ribosomes (14). These
ribosomes will reach the next start codon downstream yield-
ing p33. Smaller preS/S protein isoforms were almost not
expressed indicating that spurious 50 end-independent internal
initiation does not occur. In keeping with this notion, no IRES
activity was observed within the DHBV preS region using
a dicistronic construct. Internal initiation was therefore, un-
likely to contribute to the translation of stable 30 mRNA cleav-
age fragments.
RNase H activity has been observed in the nucleus and in
the cytoplasm, respectively(5). IfRNase H-mediated cleavage
occurred predominantly in the cytoplasm, ribosomes could
also be recruited before endonucleolytic cleavage by a cap-
dependent mechanism. These ribosomes could cycle on the
mRNA even after the capped 50 terminus had been removed by
ASO/RNase H. This hypothesis is supported by the observa-
tion that interaction between the 50 cap and eIF4E is essential
for the recruitment of ribosomes, but dispensable for each
round of translation once the ribosome cycles on the mRNA
(45). However, cap-dependent initiation before endonucleo-
lytic cleavage is unlikely to contribute to the translation of
stable 30 mRNA cleavage fragments, as we didnot observe any
RNase H activity in the cytoplasm upon cotransfection of
in vitro transcribed mRNA and ASO. RNA transfections have
been used earlier to demonstrate that a nuclear event was
required for proper IRES function on cellular RNA (46,47).
We therefore propose that a nuclear mode of action of ASO/
RNase H is involved in the generation of stable 30 mRNA
cleavage fragments. The nuclear localization of RNase H
activity is also consistent with previous reports demonstrating
that ASO also attack pre-mRNA before splicing and that
Nucleic Acids Research, 2005, Vol. 33, No. 1 123nuclear accumulation of ASO coincides with the inhibition of
gene expression (32,48,49).
It was unexpected in the light of this ﬁnding that the amount
of cytoplasmic RNA was not inﬂuenced by ASO/RNase
H-mediated cleavage, as the 50 cap structure is considered
an important enhancer of nuclear export. Such transport may
be facilitated by the fact that most hepadnaviral mRNAs are
unspliced (50), as ASO-mediated cleavage before splicing has
been shown to result in the nuclear accumulation of the RNA
(48). Cytoplasmic transport is further enhanced by a RNA
element in HBV (51), but similar structures have, to our
knowledge, not been described in DHBV. However, the
exact mechanisms supporting the nuclear export of uncapped
30 mRNA cleavage fragments remain to be elucidated.
The translational efﬁciency of stable 30 mRNA cleavage
fragments will be critical to determine the impact of our
ﬁndings for future antisense applications. Polysome analysis
and expression of ﬁreﬂy fusion proteins indicate a moderate
translational efﬁciency amounting to 13–24% compared with
translation of uncleaved mRNA, depending on the ASO used.
However, protein analysis (Figures 1C and 5C) suggests that
the efﬁciency of translation may be even higher for preS/S
proteins without the luciferase portion and may also be
inﬂuenced by structures within the target mRNA. The efﬁcien-
cies reported elsewhere were lower in yeast (4–6%) and in
a mammalian cell line (2%) (16,17). However, these efﬁcien-
cies obtained after transfection of uncapped in vitro
transcribed mRNA cannot be compared directly to the
efﬁciencies measured here after endonucleolytic cleavage of
in vivo transcribed mRNA.
Inconclusion,weprovideevidencethatASOdirectedagainst
hepadnaviral sequences speciﬁcally induce the generation of
stable 30 mRNA cleavage fragments by the action of cellular
RNaseH.Translationofthesefragmentslikelyinvolves50 end-
dependentand,atleastinpart,cap-independentinitiation.Even
if the efﬁciency of this process may be moderate, it should be
sufﬁcient to result in potential biological effects. As DHBV
transcripts are generated by host cellular polymerase II, we
assume that the phenomena examined here will also apply
to non-viral RNA. Our ﬁndings should therefore be taken
into account when designing antisense applications to prevent
potential side effects by the generation of novel polypep-
tides with unknown biological properties after ASO/RNase
H-mediated cleavage of the target mRNA.
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